After achieving a landmark settlement, in which the negligent defendants have agreed to fund immunotherapy for a claimant who has developed cancer, Michael Rawlinson QC examines the dilemma of the prospect and effect of immunotherapy in a recent blog post.
The full blog post can be found here.
FULL: Zoom Seminar: Coronavirus Job Retention Scheme Update
FULL: Zoom Seminar: Planning for Flexibility: An Interactive Seminar brought to you…
Zoom Seminar: Biodiversity Net Gain (BNG)
© Copyright 2020 Kings Chambers. All rights reserved.
Coronavirus (CoVID-19) Public Health England (PHE) recommendations – please view our important guidelines.
We have placed cookies on your device to help make this website better. You can view our cookie policy here. Continue using site